MTOR and systemic lupus erythematosus: In addition, the immunosuppressive effect of the mTOR inhibitor rapamycin is beneficial to patients with systemic autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis, and organ specific autoimmune diseases [22].